Soluble Biotech: Difference between revisions

From Bhamwiki
Jump to navigation Jump to search
No edit summary
No edit summary
Line 1: Line 1:
[[Image:Soluble Therapeutics logo.png|right|125px]]
[[Image:Soluble Therapeutics logo.png|right|125px]]
'''Soluble Therapeutics LLC''' was a company that specialized in analyzing protein formulations and establishing improvements to their solubility characteristics as a service to the pharmaceutical research industry. The company used a proprietary system to conduct analyses quickly and efficiently. The company was founded in [[2008]] as a spinoff of research performed at [[UAB]]. [[Joseph Garner]] was hired as CEO in [[2010]] to lead business development efforts. In [[2012]] the company was awarded a $1 million grant to help commercialize its technology for sale.
'''Soluble Therapeutics LLC''' was a company that specialized in analyzing protein formulations and establishing improvements to their solubility characteristics as a service to the pharmaceutical research industry. The company was founded in [[2008]] as a spinoff of research performed at [[UAB]] and was housed at the [[Innovation Depot]] in downtown [[Birmingham]]. It developed a proprietary system to conduct analyses quickly and efficiently.  


The company is housed at the [[Innovation Depot]] in downtown [[Birmingham]].
[[Joseph Garner]] was hired as CEO in [[2010]] to lead business development efforts. In [[2012]] the company was awarded a $1 million grant to help commercialize its technology for sale. In [[2014]] Soluble Therapeutics acquired Dilyx Biotechnologies of Seattle, Washington. In [[2016]] the company graduated from Innovation Depot. Later that same year it was acquired by CytoBiosciences of San Antonio, Texas. The company maintains a cell development laboratory, operated as '''Soluble BioScience''', at the Innovation Depot.
 
In [[2014]] Soluble Therapeutics acquired Dilyx Biotechnologies of Seattle, Washington. In [[2016]] the company graduated from Innovation Depot. Later that same year it was acquired by CytoBiosciences of San Antonio, Texas. It's Birmingham office was closed and all eight employees relocated to Texas.


{{stub}}
{{stub}}

Revision as of 15:26, 29 April 2019

Soluble Therapeutics logo.png

Soluble Therapeutics LLC was a company that specialized in analyzing protein formulations and establishing improvements to their solubility characteristics as a service to the pharmaceutical research industry. The company was founded in 2008 as a spinoff of research performed at UAB and was housed at the Innovation Depot in downtown Birmingham. It developed a proprietary system to conduct analyses quickly and efficiently.

Joseph Garner was hired as CEO in 2010 to lead business development efforts. In 2012 the company was awarded a $1 million grant to help commercialize its technology for sale. In 2014 Soluble Therapeutics acquired Dilyx Biotechnologies of Seattle, Washington. In 2016 the company graduated from Innovation Depot. Later that same year it was acquired by CytoBiosciences of San Antonio, Texas. The company maintains a cell development laboratory, operated as Soluble BioScience, at the Innovation Depot.

This article is a stub. You can help Bhamwiki by expanding it.

References

  • Swant, Martin (June 17, 2012) "Birmingham biotech company wins National Institutes of Health $1 million grant." The Birmingham News
  • Hoppe, Ian (July 30, 2014) "Birmingham is on the front lines of medical research: take a look at this biotech startup." The Birmingham News
  • Hoppe, Ian (October 2, 2014) "Birmingham's Soluble Therapeutics acquires Seattle company Dilyx Biotechnology." The Birmingham News
  • Brown, Melissa (December 21, 2016) "Birmingham biotech startup acquired by San Antonio company." Birmingham Business Journal

External links

Retrieved from "http://bhamwiki.com/w/index.php?title=Soluble_Biotech&oldid=156674"